Literature DB >> 17331979

Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones.

Yuxi Shan1, Eleonora Napoli, Gino Cortopassi.   

Abstract

The neurodegenerative disorder Friedreich's ataxia (FRDA) is caused by mutations in frataxin, a mitochondrial protein whose function remains controversial. Using co-immunoprecipitation and mass spectrometry we identified multiple interactors of mitochondrial frataxin in mammalian cells. One interactor was mortalin/GRP75, a homolog of the yeast ssq1 chaperone that integrates iron-sulfur clusters into imported mitochondrial proteins. Another interactor was ISD11, recently identified as a component of the eukaryotic complex Nfs1/ISCU, an essential component of iron-sulfur cluster biogenesis. Interactions between frataxin and ISD11, and frataxin and GRP75 were confirmed by co-immunoprecipitation experiments in both directions. Immunofluorescence analysis demonstrated that ISD11 co-localized with both frataxin and with mitochondria. The point mutations I154F and W155R in frataxin cause FRDA and are clustered to one surface of the protein, and these mutations decrease the interaction of frataxin with ISD11. The frataxin/ISD11 interaction was also decreased by the chelator EDTA, and was increased by supplementation with nickel but not other metal ions. Nickel supplementation rescued the defective interaction of mutant frataxin I154F and W155R with ISD11. Upon ISD11 depletion by siRNA in HEK293T cells, the amount of the Nfs1/ISCU protein complex declined, as did the activity of the iron-sulfur cluster enzyme aconitase, while the cellular iron content was increased, as seen in tissues from FRDA patients. Furthermore, ISD11 mRNA levels were decreased in FRDA patient cells. These data suggest that frataxin binds the iron-sulfur biogenesis Nfs1/ISCU complex through ISD11, that the interaction is nickel-dependent, and that multiple consequences of frataxin deficiency are duplicated by ISD11 deficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331979     DOI: 10.1093/hmg/ddm038

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  63 in total

1.  HSC20 interacts with frataxin and is involved in iron-sulfur cluster biogenesis and iron homeostasis.

Authors:  Yuxi Shan; Gino Cortopassi
Journal:  Hum Mol Genet       Date:  2011-12-13       Impact factor: 6.150

Review 2.  ATAD3, a vital membrane bound mitochondrial ATPase involved in tumor progression.

Authors:  Shuijie Li; Denis Rousseau
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

3.  Structural, Mechanistic and Coordination Chemistry of Relevance to the Biosynthesis of Iron-Sulfur and Related Iron Cofactors.

Authors:  Wenbin Qi; J A Cowan
Journal:  Coord Chem Rev       Date:  2011-04-01       Impact factor: 22.315

Review 4.  Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.

Authors:  Ngolela E Babady; Nadege Carelle; Robert D Wells; Tracey A Rouault; Michio Hirano; David R Lynch; Martin B Delatycki; Robert B Wilson; Grazia Isaya; Hélène Puccio
Journal:  Mol Genet Metab       Date:  2007-06-26       Impact factor: 4.797

Review 5.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

6.  Friedreich's ataxia variants I154F and W155R diminish frataxin-based activation of the iron-sulfur cluster assembly complex.

Authors:  Chi-Lin Tsai; Jennifer Bridwell-Rabb; David P Barondeau
Journal:  Biochemistry       Date:  2011-06-29       Impact factor: 3.162

7.  Key players and their role during mitochondrial iron-sulfur cluster biosynthesis.

Authors:  Swati Rawat; Timothy L Stemmler
Journal:  Chemistry       Date:  2011-01-05       Impact factor: 5.236

8.  Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.

Authors:  R Mark Payne; P Melanie Pride; Clifford M Babbey
Journal:  Pediatr Cardiol       Date:  2011-03-01       Impact factor: 1.655

9.  Iron-binding activity in yeast frataxin entails a trade off with stability in the alpha1/beta1 acidic ridge region.

Authors:  Ana R Correia; Tao Wang; Elizabeth A Craig; Cláudio M Gomes
Journal:  Biochem J       Date:  2010-02-09       Impact factor: 3.857

10.  Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia.

Authors:  Giovanni Coppola; Daniele Marmolino; Daning Lu; Qing Wang; Miriam Cnop; Myriam Rai; Fabio Acquaviva; Sergio Cocozza; Massimo Pandolfo; Daniel H Geschwind
Journal:  Hum Mol Genet       Date:  2009-04-17       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.